from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3380c/-

LFCtreatmentdescriptionclass of inhibitor

-0.285

Amikacinug/mL Amikacintranslation

0.621

Cap5-10ug/mL Capreomycintranslation

-0.073

Rox10-50 ug/mL Roxithromycintranslation

-0.120

SM2-5 ug/mL Streptomycintranslation

-0.029

Tet5-10 ug/mL Tetracyclinetranslation

-1.252

Rif0.2-5ug/mL Rifampicintranscription

-0.038

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.156

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.675

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.014

CPZ10-50 ug/mL Chlorpromazinerespiration

0.424

Clofazimine10-13 ug/mL Clofaziminerespiration

0.841

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.772

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.370

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.565

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.099

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.119

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.015

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.584

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.745

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.012

KCN5-20 ug/mL Potassium cyaniderespiration

0.415

NaN30.2-2 mM Sodium aziderespiration

1.169

Nigericin50 uM Nigericinrespiration

-0.172

TRC10-150 ug/mL Triclosanrespiration

-0.485

TRZ10-25 ug/mL Thioridazinerespiration

2.497

Valinomycin0.5-10 uM Valinomycinrespiration

0.984

ZnSO42 mM ZnSO4respiration

-0.077

menadione6-10 ug/mL Menadionerespiration

-0.288

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.461

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.029

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.649

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.308

NRP_1Non-replicating persistence stage 1dosRassociated

0.209

Amp0.2mg/mL AmpicillincellWall

-0.105

Cephalexin20-100 ug/mL CephalexincellWall

-0.049

Cerulenin0.32-5 ug/mL CerulenincellWall

0.156

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.415

EMB10-20 ug/mL EthambutolcellWall

-0.231

Eta12-40 ug/mL EthionamidecellWall

-0.564

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.352

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.107

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.063

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.283

BZA0.12 mg/mL BenzamidearomaticAmides

-0.618

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.557

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.232

H2O24 mM hydrogen peroxideDNAdamaging

-0.186

Levo10 ug/mL LevofloxacinDNAdamaging

-0.441

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.532

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.220

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.109

UVUV-irradiationDNAdamaging

-0.679

ARP41-4 ug/mL Antitubercular compound ARP4?

0.160

Antimycin12.5-50 ug/mL Antimycin A?

0.786

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.000

PA_110-50 ug/mL Antitubercular compound PA-1?

0.863

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.324

PA8240.2-2 ug/mL PA-824?

-0.510

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.059

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.530

Verapamil50 uM Verapamil?

0.496

mercaptoethanol2 mM 2-Mercaptoethanol?

0.603

methoxatin10-20 ug/mL Methoxatin?